About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [313 citations: 1–100 of 312 articles]

Articles published in Chemotherapy Research and Practice have been cited 313 times. The following is a list of the 312 articles that have cited the articles published in Chemotherapy Research and Practice.

  • Chih-Sheng Chiang, Yi-Hsuan Tseng, Bang-Jie Liao, and San Yuan Chen, “Magnetically Targeted Nanocapsules for PAA-Cisplatin-Conjugated Cores in PVA/SPIO Shells via Surfactant-Free Emulsion for Reduced Nephrotoxicity and Enhanced Lung Cancer Therapy,” Advanced Healthcare Materials, 2015. View at Publisher · View at Google Scholar
  • S. Trivedi, F. Concha-Benavente, R. M. Srivastava, H. B. Jie, S. P. Gibson, N. C. Schmitt, and R. L. Ferris, “Immune biomarkers of anti-EGFR monoclonal antibody therapy,” Annals Of Oncology, vol. 26, no. 1, pp. 40–47, 2015. View at Publisher · View at Google Scholar
  • C. Bisschop, J. J. J. Tjalma, G. A. P. Hospers, D. Van Geldere, J. W. B. de Groot, E. M. Wiegman, M. Van't Veer-ten Kate, M. G. Havenith, J. Vecht, J. C. Beukema, G. Kats-Ugurlu, S. V. K. Mahesh, B. van Etten, K. Havenga, J. G. M. Burgerhof, D. J. A. de Groot, and W. H. de Vos Tot Nederveen Cappel, “Consequence of Restaging After Neoadjuvant Treatment for Locally Advanced Rectal Cancer,” Annals Of Surgical Oncology, vol. 22, no. 2, pp. 552–556, 2015. View at Publisher · View at Google Scholar
  • Damoun Safarpour, and Fattaneh A. Tavassoli, “A Targetable Androgen Receptor–Positive Breast Cancer Subtype Hidden Among the Triple-Negative Cancers,” Archives of Pathology & Laboratory Medicine, vol. 139, no. 5, pp. 612–617, 2015. View at Publisher · View at Google Scholar
  • Takashi Hoshiba, and Masaru Tanaka, “Optimization of the tissue source, malignancy, and initial substrate of tumor cell-derived matrices to increase cancer cell chemoresistance against 5-fluorouracil,” Biochemical and Biophysical Research Communications, 2015. View at Publisher · View at Google Scholar
  • Carlos A. López-Morales, Mariana P. Miranda-Hernández, L. Carmina Juárez-Bayardo, Nancy D. Ramírez-Ibáñez, Alexis J. Romero-Díaz, Nelly Piña-Lara, Víctor R. Campos-García, Néstor O. Pérez, Luis F. Flores-Ortiz, and Emilio Medina-Rivero, “Physicochemical and Biological Characterization of a Biosimilar Trastuzumab,” BioMed Research International, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Kai-Jie Kao, Chien-Hsuan Tai, Wen-Hsin Chang, Ta-Sen Yeh, Tse-Ching Chen, and Gwo-Bin Lee, “A fluorescence in situ hybridization (FISH) microfluidic platform for detection of HER2 amplification in cancer cells,” Biosensors and Bioelectronics, vol. 69, pp. 272–279, 2015. View at Publisher · View at Google Scholar
  • Gerwyn Morris, Michael Berk, Ken Walder, and Michael Maes, “Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses,” BMC Medicine, vol. 13, no. 1, 2015. View at Publisher · View at Google Scholar
  • Kristian Barlinn, Hans Lehrach, Timo Siepmann, David Braeuer, Ulrich Buntrock, and Norbert Sassim, “Temporary loss of moral behavior in a patient undergoing chemotherapy with cisplatin - breaking bad,” Bmc Psychiatry, vol. 15, 2015. View at Publisher · View at Google Scholar
  • Callie R. Merry, Sarah McMahon, Cheryl L. Thompson, Kristy L. S. Miskimen, Lyndsay N. Harris, and Ahmad M. Khalil, “Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+breast cancer,” Breast Cancer Research And Treatment, vol. 150, no. 2, pp. 321–334, 2015. View at Publisher · View at Google Scholar
  • É. Le Rhun, C. Mateus, L. Mortier, F. Dhermain, B. Guillot, J.-J. Grob, C. Lebbe, M. Thomas, T. Jouary, M.-T. Leccia, and C. Robert, “Traitement systémique des métastases cérébrales de mélanome,” Cancer/Radiothérapie, 2015. View at Publisher · View at Google Scholar
  • Richard J. Albertini, Elizabeth W. Carter, Janice A. Nicklas, Pamela M. Vacek, and Vernon E. Walker, “1,3-Butadiene, CML and the t(9:22) translocation: A reality check,” Chemico-Biological Interactions, 2015. View at Publisher · View at Google Scholar
  • Xiao-Yun Hu, Ji-Yun Liang, Xue-Jun Guo, Li Liu, and Ya-Bing Guo, “5-Fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (Delta Psi m)-mediated apoptosis in hepato,” Clinical And Experimental Pharmacology And Physiology, vol. 42, no. 2, pp. 146–153, 2015. View at Publisher · View at Google Scholar
  • Bin-Chi Liao, Yu-Yun Shao, Ho-Min Chen, Wen-Yi Shau, Zhong-Zhe Lin, Raymond Nienchen Kuo, Chiu-Ling Lai, Kuo-Hsing Chen, Ann-Lii Cheng, James Chih-Hsin Yang, and Mei-Shu Lai, “Comparative Effectiveness of First-Line Platinum-Based Chemotherapy Regimens for Advanced Lung Squamous Cell Carcinoma,” Clinical Lung Cancer, vol. 16, no. 2, pp. 137–143, 2015. View at Publisher · View at Google Scholar
  • Wolfgang Marx, Karin Ried, Alexandra L McCarthy, Luis Vitetta, Avni Sali, Daniel McKavanagh, and Elisabeth Isenring, “Ginger—Mechanism of Action in Chemotherapy-induced Nausea and Vomiting: A Review,” Critical Reviews in Food Science and Nutrition, pp. 00–00, 2015. View at Publisher · View at Google Scholar
  • Geng Guo, Cheng-liang Zhong, Yang Liu, Xing-gang Mao, Zheng Zhang, Ji Jin, Jing Liu, Liu Yang, Jin-ming Mao, Yu-hong Guo, and Yuan-li Zhao, “Overexpression of FRAT1 Is Associated with Malignant Phenotype and Poor Prognosis in Human Gliomas,” Disease Markers, vol. 2015, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  • Raphael Tavares, Nicole M. Scherer, Carlos G. Ferreira, Fabricio F. Costa, and Fabio Passetti, “Splice variants in the proteome: a promising and challenging field to targeted drug discovery,” Drug Discovery Today, vol. 20, no. 3, pp. 353–360, 2015. View at Publisher · View at Google Scholar
  • J. Gras, “ABITUZUMAB Anti-Integrin alpha(nu) (CD51, ITGAV) MAb, Oncolytic,” Drugs Of The Future, vol. 40, no. 2, pp. 97–100, 2015. View at Publisher · View at Google Scholar
  • Sree Harsha, Bandar E. Al-Dhubiab, Anroop B. Nair, Mohammed Al-Khars, Mohammed Al-Hassan, Raja Rajan, Mahesh Attimarad, Katharigatta N. Venugopala, and Afzal Haq Asif, “Novel Drying Technology of Microsphere and Its Evaluation for Targeted Drug Delivery for Lungs,” Drying Technology, vol. 33, no. 4, pp. 502–512, 2015. View at Publisher · View at Google Scholar
  • Manu M. Joseph, S.R. Aravind, Suraj K. George, K. Raveendran Pillai, S. Mini, and T.T. Sreelekha, “Anticancer activity of galactoxyloglucan polysaccharide–conjugated doxorubicin nanoparticles: mechanistic insights and interactome analysis,” European Journal of Pharmaceutics and Biopharmaceutics, 2015. View at Publisher · View at Google Scholar
  • Pamela Ovadje, Alessia Roma, Matthew Steckle, Leah Nicoletti, John Thor Arnason, and Siyaram Pandey, “Advances in the Research and Development of Natural Health Products as Main Stream Cancer Therapeutics,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Giovanni Sortino, Francesco Passiglia, Sergio Rizzo, Francesca Lo Vullo, Antonio Galvano, Viviana Bazan, Christian Rolfo, Antonio Russo, and Giuseppe Bronte, “Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario,” Expert Opinion On Biological Therapy, vol. 15, no. 1, pp. 45–59, 2015. View at Publisher · View at Google Scholar
  • Fiona Taylor, and Barry W. Hancock, “Pharmacotherapy of placental site and epithelioid trophoblastic tumours,” Expert Opinion On Orphan Drugs, vol. 3, no. 1, pp. 75–85, 2015. View at Publisher · View at Google Scholar
  • Sreena Raj, and K.M. Gothandam, “Immunomodulatory activity of methanolic extract of Amorphophallus commutatus var. wayanadensis under normal and cyclophosphamide induced immunosuppressive conditions in mice models,” Food and Chemical Toxicology, 2015. View at Publisher · View at Google Scholar
  • Matthias Kreppel, Nilofar-Natalie Amir Manawi, Martin Scheer, Hans-Joachim Nickenig, Daniel Rothamel, Timo Dreiseidler, Uta Drebber, Max Zinser, Joachim E. Zoeller, Orlando Guntinas-Lichius, and Simon Florian Preuss, “Prognostic quality of the Union Internationale Contre le Cancer/American Joint Committee on Cancer TNM classification, 7th edition, for cancer of the ,” Head And Neck-Journal For The Sciences And Specialties Of The Head And Neck, vol. 37, no. 3, pp. 400–406, 2015. View at Publisher · View at Google Scholar
  • Xiaofang Hu, Yan Cao, Yiming Meng, and Mingxiao Hou, “A novel modulation of structural and functional changes of mouse bone marrow derived dendritic cells (BMDCs) by interleukin-2(IL-2),” Human Vaccines & Immunotherapeutics, vol. 11, no. 2, pp. 516–521, 2015. View at Publisher · View at Google Scholar
  • Satvir Sekhon-Loodu, Ziaullah, and H.P. Vasantha Rupasinghe, “Docosahexaenoic acid ester of phloridzin inhibit lipopolysaccharide-induced inflammation in THP-1 differentiated macrophages,” International Immunopharmacology, 2015. View at Publisher · View at Google Scholar
  • Nanxin Li, Yanni Hao, Jipan Xie, Peggy L. Lin, Valerie Koo, Erika Ohashi, and Eric Q. Wu, “Everolimus-Based Therapy versus Chemotherapy among Patients with HR+/HER2− Metastatic Breast Cancer: Comparative Effectiveness from a Chart Review Study,” International Journal of Breast Cancer, vol. 2015, pp. 1–9, 2015. View at Publisher · View at Google Scholar
  • Valeria Maria Piccolini, Alessandra Esposito, Veronica Dal Bo, Violetta Insolia, Maria Grazia Bottone, Sandra Angelica De Pascali, Francesco Paolo Fanizzi, and Graziella Bernocchi, “Cerebellum neurotransmission during postnatal development: [Pt(O,O '-acac)(gamma-acac)(DMS)] vs cisplatin and neurotoxicity,” International Journal Of Developmental Neuroscience, vol. 40, pp. 24–34, 2015. View at Publisher · View at Google Scholar
  • Giuseppina Bozzuto, and Agnese Molinari, “Liposomes as nanomedical devices,” International Journal of Nanomedicine, vol. 10, pp. 975–999, 2015. View at Publisher · View at Google Scholar
  • Jie Tang, Fuchun Guo, Yang Du, Xiaoling Liu, Qing Qin, Xiaoke Liu, Tao Yin, Li Jiang, and Yongsheng Wang, “Continuous exposure of non-small cell lung cancer cells with wild-type EGFR to an inhibitor of EGFR tyrosine kinase induces chemoresistance by activat,” International Journal Of Oncology, vol. 46, no. 5, pp. 2083–2095, 2015. View at Publisher · View at Google Scholar
  • Matthew M. Kwok, and Paul Goodyear, “Prognostic and Predictive Protein Biomarkers in Laryngeal Squamous Cell Carcinoma—A Systematic Review,” International Journal of Otolaryngology and Head & Neck Surgery, vol. 04, no. 03, pp. 180–189, 2015. View at Publisher · View at Google Scholar
  • N. N. Basu, L. Barr, G. L. Ross, and D. G. Evans, “Contralateral Risk-Reducing Mastectomy: Review of Risk Factors and Risk-Reducing Strategies,” International Journal of Surgical Oncology, vol. 2015, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • B. Ravi Shankar, Poojar Kiran, B. V. Madhavi, and E. Vijay, “Concurrent Nimotuzumab with Radiation Therapy in Locally Advanced Cancers of Oropharynx and Hypopharynx: A Review of 6 Cases,” Journal of Cancer Therapy, vol. 06, no. 04, pp. 390–398, 2015. View at Publisher · View at Google Scholar
  • Koji Matsuo, Seiji Mabuchi, Mika Okazawa, Mahiru Kawano, Hiromasa Kuroda, Shoji Kamiura, and Tadashi Kimura, “Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors,” Journal Of Gynecologic Oncology, vol. 26, no. 1, pp. 3–11, 2015. View at Publisher · View at Google Scholar
  • Federica Maria Di Maggio, Luigi Minafra, Giusi Irma Forte, Francesco Paolo Cammarata, Domenico Lio, Cristina Messa, Maria Carla Gilardi, and Valentina Bravatà, “Portrait of inflammatory response to ionizing radiation treatment,” Journal of Inflammation, vol. 12, no. 1, 2015. View at Publisher · View at Google Scholar
  • Roberta Salaroli, Alice Ronchi, Francesca Romana Buttarelli, Filippo Cortesi, Valeria Marchese, Elena Della Bella, Cristiano Renna, Caterina Baldi, Felice Giangaspero, and Giovanna Cenacchi, “Wnt activation affects proliferation, invasiveness and radiosensitivity in medulloblastoma,” Journal Of Neuro-Oncology, vol. 121, no. 1, pp. 119–127, 2015. View at Publisher · View at Google Scholar
  • Kevin A. Harvey, Zhidong Xu, M. Reza Saaddatzadeh, Haiyan Wang, Karen Pollok, Aaron A. Cohen-Gadol, and Rafat A. Siddiqui, “Enhanced anticancer properties of lomustine in conjunction with docosahexaenoic acid in glioblastoma cell lines,” Journal Of Neurosurgery, vol. 122, no. 3, pp. 547–556, 2015. View at Publisher · View at Google Scholar
  • Marta Simo, James C. Root, Lucia Vaquero, Pablo Ripolles, Josep Jove, Tim Ahles, Arturo Navarro, Felipe Cardenal, Jordi Bruna, and Antoni Rodriguez-Fornells, “Cognitive and Brain Structural Changes in a Lung Cancer Population,” Journal Of Thoracic Oncology, vol. 10, no. 1, pp. 38–45, 2015. View at Publisher · View at Google Scholar
  • Ee Xien Ng, Miles A. Miller, Tengyang Jing, Doug A. Lauffenburger, and Chia-Hung Chen, “Low-volume multiplexed proteolytic activity assay and inhibitor analysis through a pico-injector array,” Lab Chip, vol. 15, no. 4, pp. 1153–1159, 2015. View at Publisher · View at Google Scholar
  • Engy M. Aboelnaga, Mohamed A. Daoud, Entesar I. Eladl, and Amir M. Zaid, “Induction FOLFOX followed by preoperative hyperfractionated radiotherapy plus bolus 5-fluorouracil in locally advanced rectal carcinoma: single arm ph,” Medical Oncology, vol. 32, no. 4, 2015. View at Publisher · View at Google Scholar
  • James P. Caruso, Or Cohen-Inbar, Mark H. Bilsky, Peter C. Gerszten, and Jason P. Sheehan, “Stereotactic radiosurgery and immunotherapy for metastatic spinal melanoma,” Neurosurgical Focus, vol. 38, no. 3, pp. E6, 2015. View at Publisher · View at Google Scholar
  • Analhuda Abdullah Tahir, Nur Fathiah Abdul Sani, Noor Azian Murad, Suzana Makpol, Wan Zurinah Wan Ngah, and Yasmin Anum Mohd Yusof, “Combined ginger extract & Gelam honey modulate Ras/ERK and PI3K/AKT pathway genes in colon cancer HT29 cells,” Nutrition Journal, vol. 14, no. 1, 2015. View at Publisher · View at Google Scholar
  • Shunchao Yan, Xin Jiao, Kai Li, Wusheng Li, and Huawei Zou, “The impact of IGF-IR expression on the outcomes of patients with breast cancer: a meta-analysis,” Oncotargets And Therapy, vol. 8, pp. 279–287, 2015. View at Publisher · View at Google Scholar
  • S. Koeppen, “Peripheral neurotoxicity. Preventive dosage modification,” Onkologe, vol. 21, no. 4, pp. 311–+, 2015. View at Publisher · View at Google Scholar
  • Terence M. Myckatyn, Jaime A. Cavallo, Ketan Sharma, Noopur Gangopadhyay, Jason R. Dudas, Andres A. Roma, Sara Baalman, Marissa M. Tenenbaum, Brent D. Matthews, and Corey R. Deeken, “The Impact of Chemotherapy and Radiation Therapy on the Remodeling of Acellular Dermal Matrices in Staged, Prosthetic Breast Reconstruction,” Plastic And Reconstructive Surgery, vol. 135, no. 1, pp. 43E–57E, 2015. View at Publisher · View at Google Scholar
  • Nicolas Carels, Tatiana Tilli, and Jack A. Tuszynski, “A Computational Strategy to Select Optimized Protein Targets for Drug Development toward the Control of Cancer Diseases,” Plos One, vol. 10, no. 1, 2015. View at Publisher · View at Google Scholar
  • Nadege Gaborit, Ali Abdul-Hai, Maicol Mancini, Moshit Lindzen, Sara Lavi, Orith Leitner, Lucile Mounier, Myriam Chentouf, Sai Dunoyer, Manjusha Ghosh, Christel Larbouret, Thierry Chardes, Herve Bazin, Andre Pelegrine, Michael Sela, and Yosef Yarden, “Examination of HER3 targeting in cancer using monoclonal antibodies,” Proceedings Of The National Academy Of Sciences Of The United States Of America, vol. 112, no. 3, pp. 839–844, 2015. View at Publisher · View at Google Scholar
  • Hung-Jin Huang, Hsin-Yi Chen, Yuan-Shiun Chang, and Calvin Yu-Chian Chen, “Insight into two antioxidants binding to the catalase NADPH binding site from traditional Chinese medicines,” Rsc Advances, vol. 5, no. 9, pp. 6625–6635, 2015. View at Publisher · View at Google Scholar
  • Matthew P. Walker, Charles M. Stopford, Maria Cederlund, Fang Fang, Christopher Jahn, Alex D. Rabinowitz, Dennis Goldfarb, David M. Graham, Feng Yan, Allison M. Deal, Yuri Fedoriw, Kristy L. Richards, Ian J. Davis, Gilbert Weidinger, Blossom Damania, and Michael B. Major, “FOXP1 potentiates Wnt/beta-catenin signaling in diffuse large B cell lymphoma,” Science Signaling, vol. 8, no. 362, 2015. View at Publisher · View at Google Scholar
  • J. S. Davis, S. Van Hal, and S. Y. C. Tong, “Combination Antibiotic Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections,” Seminars In Respiratory And Critical Care Medicine, vol. 36, no. 1, pp. 3–16, 2015. View at Publisher · View at Google Scholar
  • M. A. Jallad, R. Naoufal, J. Irani, and E. Azar, “Extended Spectrum Beta-Lactamase Carriage State among Elderly Nursing Home Residents in Beirut,” The Scientific World Journal, vol. 2015, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Denisa Margină, Mihaela Ilie, Daniela Grădinaru, Vasilis P. Androutsopoulos, Demetrios Kouretas, and Aristidis Tsatsakis, “Natural products—friends or foes?,” Toxicology Letters, 2015. View at Publisher · View at Google Scholar
  • Marwan Ghosn, Hampig Raphael Kourie, Pamela Abdayem, Joelle Antoun, and Dolly Nasr, “Anal cancer treatment: Current status and future perspectives,” World Journal Of Gastroenterology, vol. 21, no. 8, pp. 2294–2302, 2015. View at Publisher · View at Google Scholar
  • Na Li, Gang Chen, Jue Liu, Yang Xia, Hanbang Chen, Hui Tang, Feimin Zhang, and Ning Gu, “Effect of Surface Topography and Bioactive Properties on Early Adhesion and Growth Behavior of Mouse Preosteoblast MC3T3-E1 Cells,” Acs Applied Materials & Interfaces, vol. 6, no. 19, pp. 17134–17143, 2014. View at Publisher · View at Google Scholar
  • Jing Liu, Il-Hoon Cho, Yi Cui, and Joseph Irudayaraj, “Second Harmonic Super-resolution Microscopy for Quantification of mRNA at Single Copy Sensitivity,” Acs Nano, vol. 8, no. 12, pp. 12418–12427, 2014. View at Publisher · View at Google Scholar
  • Youngseok Lee, Jian Ma, Hui Lyu, Jingcao Huang, and Aeree Kim, “Role of erbB3 receptors in cancer therapeutic resistance,” Acta Biochimica et Biophysica Sinica, vol. 46, no. 3, pp. 190–198, 2014. View at Publisher · View at Google Scholar
  • Maria Hakanson, Edna Cukierman, and Mirren Charnley, “Miniaturized pre-clinical cancer models as research and diagnostic tools,” Advanced Drug Delivery Reviews, vol. 69, pp. 52–66, 2014. View at Publisher · View at Google Scholar
  • Sylvia Kiwuwa-Muyingo, Bernard Kikaire, Ivan Mambule, Helen Musana, Godfrey Musoro, Charles F. Gilks, Jonathan B. Levin, and Anne Sarah Walker, “Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial,” Aids, vol. 28, no. 17, pp. 2579–2588, 2014. View at Publisher · View at Google Scholar
  • Paul Lochhead, Andrew T. Chan, Edward Giovannucci, Charles S. Fuchs, Kana Wu, Reiko Nishihara, Michael O'Brien, and Shuji Ogino, “Progress and Opportunities in Molecular Pathological Epidemiology of Colorectal Premalignant Lesions,” American Journal of Gastroenterology, vol. 109, no. 8, pp. 1205–1214, 2014. View at Publisher · View at Google Scholar
  • Xinghao Ai, Yingjia Sun, Haidong Wang, and Shun Lu, “A systematic profile of clinical inhibitors responsive to EGFR somatic amino acid mutations in lung cancer: implication for the molecular mechanism of drug resistance and sensitivity,” Amino Acids, vol. 46, no. 7, pp. 1635–1648, 2014. View at Publisher · View at Google Scholar
  • Yujun Song, Xuefeng Xia, Xifeng Wu, Ping Wang, and Lidong Qin, “Integration of Platinum Nanoparticles with a Volumetric Bar-Chart Chip for Biomarker Assays,” Angewandte Chemie-International Edition, vol. 53, no. 46, pp. 12451–12455, 2014. View at Publisher · View at Google Scholar
  • Chongjiao Li, Xiaoli Lan, Hui Yuan, Hongyan Feng, Xiaotian Xia, and Yongxue Zhang, “F-18-FDG PET predicts pathological response to preoperative chemoradiotherapy in patients with primary rectal cancer: a meta-analysis,” Annals of Nuclear Medicine, vol. 28, no. 5, pp. 436–446, 2014. View at Publisher · View at Google Scholar
  • Edgar D. Staren, Donald Braun, Bradford Tan, Digant Gupta, Seungchan Kim, Kim Kramer, and Maurie Markman, “Initial Experience with Genomic Profiling of Heavily Pretreated Breast Cancers,” Annals of Surgical Oncology, vol. 21, no. 10, pp. 3216–3222, 2014. View at Publisher · View at Google Scholar
  • Margherita Ratti, “Emerging combination therapies to overcome resistance in EGFR-driven tumors,” Anti-Cancer Drugs, vol. 25, no. 2, pp. 127–139, 2014. View at Publisher · View at Google Scholar
  • Parisa Ghanbari, Mahsa Mohseni, Maryam Tabasinezhad, Bahman Yousefi, Amir Ata Saei, Simin Sharifi, Mohammad Reza Rashidi, and Nasser Samadi, “Inhibition of Survivin Restores the Sensitivity of Breast Cancer Cells to Docetaxel and Vinblastine,” Applied Biochemistry and Biotechnology, 2014. View at Publisher · View at Google Scholar
  • Saul Renan Leon-Hernandez, Eleazar Lara Padilla, Alfredo Cortes Algara, Noemi Cardenas Rodriguez, Esau Floriano Sanchez, Jaime Lopez Cruz, Cesar Miguel Mejia Barradas, and Cindy Bandala, “Relation of Alcohol/Tobacco use with Metastasis, Hormonal (Estrogen and Progesterone) Receptor Status and c-erbB2 Protein in Mammary Ductal Carcinoma,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 14, pp. 5709–5714, 2014. View at Publisher · View at Google Scholar
  • Nusrat Bano, Rahila Najam, Faaiza Qazi, and Ahmed Mateen, “Gastrointestinal Adverse Effects in Advanced Colorectal Carcinoma Patients Treated with Different Schedules of FOLFOX,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 19, pp. 8089–8093, 2014. View at Publisher · View at Google Scholar
  • Sabit Sinan Ozalp, Elcin Telli, Tufan Oge, Gokhan Tulunay, Nurettin Boran, Taner Turan, Mufit Yenen, Zehra Kurdoglu, Ali Ozler, Kunter Yuce, Volkan Ulker, Macit Arvas, Fuat Demirkiran, Tugan Bese, Nedim Tokgozoglu, Anil Onan, Muzaffer Sanci, Mehmet Gokcu, Gokhan Tosun, Yilmaz Dikmen, Aydin Ozsaran, Mustafa Cosan Terek, Levent Akman, Hakan Yetimalar, Derya Sakarya Kilic, Tayfun Gungor, Emre Ozgu, Yunus Yildiz, Arif Kokcu, Mehmet Kefeli, Serkan Kuruoglu, Hasan Yuksel, Tevfik Guvenal, Pinar Solmaz Hasdemir, Bulent Ozcelik, Serdar Serin, Mehmet Dolanbay, Dagistan Tolga Arioz, Nadire Tuncer, Hasan Bozkaya, Suleyman Guven, Deniz Kulaksiz, Fusun Varol, Ali Yanik, Gonca Ogurlu, Tayyup Simsek, Tayfun Toptas, Selen Dogan, Hakan Camuzoglu, Murat Api, Kadir Guzin, Eray Caliskan, Emek Doger, Bulent Cakmak, and Tolgay Tuyan Ilhan, “Multicenter Analysis of Gestational Trophoblastic Neoplasia in Turkey,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 8, pp. 3625–3628, 2014. View at Publisher · View at Google Scholar
  • Helen Creedon, Adam Byron, Joanna Main, Larry Hayward, Teresa Klinowska, and Valerie G. Brunton, “Exploring mechanisms of acquired resistance to HER2 (human epidermal growth factor receptor 2)-targeted therapies in breast cancer,” Biochemical Society Transactions, vol. 42, pp. 822–830, 2014. View at Publisher · View at Google Scholar
  • Veronica Morente, Raquel Perez-Sen, Felipe Ortega, Jaime Huerta-Cepas, Esmerilda G. Delicado, and Ma Teresa Miras-Portugal, “Neuroprotection elicited by P2Y(13) receptors against genotoxic stress by inducing DUSP2 expression and MAPK signaling recovery,” Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1843, no. 9, pp. 1886–1898, 2014. View at Publisher · View at Google Scholar
  • J. A. Smith, T. Leonardi, B. Huang, N. Iraci, B. Vega, and S. Pluchino, “Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases,” Biogerontology, 2014. View at Publisher · View at Google Scholar
  • Yijie Lu, Ghislaine Ngo Ndjock Mbong, Peng Liu, Conrad Chan, Zhongli Cai, Dirk Weinrich, Amanda J. Boyle, Raymond M. Reilly, and Mitchell A. Winnik, “Synthesis of Polyglutamide-Based Metal-Chelating Polymers and Their Site-Specific Conjugation to Trastuzumab for Auger Electron Radioimmunotherapy,” Biomacromolecules, vol. 15, no. 6, pp. 2027–2037, 2014. View at Publisher · View at Google Scholar
  • Sandhya V. G. Nair, Menik Hettihewa, and H. P. Vasantha Rupasinghe, “Apoptotic and Inhibitory Effects on Cell Proliferation of Hepatocellular Carcinoma HepG2 Cells by Methanol Leaf Extract of Costus speciosus,” BioMed Research International, vol. 2014, pp. 1–10, 2014. View at Publisher · View at Google Scholar
  • Peeyush N. Goel, and Rajiv P. Gude, “Pentoxifylline regulates the cellular adhesion and its allied receptors to extracellular matrix components in breast cancer cells,” Biomedicine & Pharmacotherapy, vol. 68, no. 1, pp. 93–99, 2014. View at Publisher · View at Google Scholar
  • Liyan Jiang, Wei Zhu, Katie Streicher, Chris Morehouse, Philip Brohawn, Xiaoxiao Ge, Zhengwei Dong, Xiaolu Yin, Guanshan Zhu, Yi Gu, Koustubh Ranade, Brandon W. Higgs, Yihong Yao, and Jiaqi Huang, “Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinoma,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Graziele Fonseca de Sousa, Samarina Rodrigues Wlodarczyk, and Gisele Monteiro, “Carboplatin: molecular mechanisms of action associated with chemoresistance,” Brazilian Journal Of Pharmaceutical Sciences, vol. 50, no. 4, pp. 693–701, 2014. View at Publisher · View at Google Scholar
  • Xinghua Li, Weijiang Liang, Junling Liu, Chuyong Lin, Shu Wu, Libing Song, and Zhongyu Yuan, “Transducin (beta)-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signaling,” Breast Cancer Research, vol. 16, no. 5, 2014. View at Publisher · View at Google Scholar
  • Lu Chen, Hannah M. Linden, Benjamin O. Anderson, and Christopher I. Li, “Trends in 5-year survival rates among breast cancer patients by hormone receptor status and stage,” Breast Cancer Research and Treatment, vol. 147, no. 3, pp. 609–616, 2014. View at Publisher · View at Google Scholar
  • S. Li, L. Li, Y. Zhu, C. Huang, Y. Qin, H. Liu, L. Ren-Heidenreich, B. Shi, H. Ren, X. Chu, J. Kang, W. Wang, J. Xu, K. Tang, H. Yang, Y. Zheng, J. He, G. Yu, and N. Liang, “Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts,” British Journal of Cancer, vol. 110, no. 11, pp. 2812–2820, 2014. View at Publisher · View at Google Scholar
  • C. L. Schwab, S. Bellone, D. P. English, D. M. Roque, S. Lopez, E. Cocco, R. Nicoletti, I. Bortolomai, E. Bonazzoli, E. Ratner, D-A Silasi, M. Azodi, P. E. Schwartz, T. J. Rutherford, and A. D. Santin, “Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo,” British Journal of Cancer, vol. 111, no. 9, pp. 1750–1756, 2014. View at Publisher · View at Google Scholar
  • M. Koczywas, P. H. Frankel, T. W. Synold, H-J Lenz, J. E. Mortimer, A. B. El-Khoueiry, D. R. Gandara, M. C. Cristea, V. M. Chung, D. Lim, K. L. Reckamp, D. H. Lau, L. A. Doyle, C. Ruel, M. I. Carroll, and E. M. Newman, “Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumors,” British Journal Of Cancer, vol. 111, no. 12, pp. 2268–2274, 2014. View at Publisher · View at Google Scholar
  • Matthew T. Balmer, Ryan D. Katz, Si Liao, James S. Goodwine, and Susannah Gal, “Doxorubicin and 5-fluorouracil induced accumulation and transcriptional activity of p53 are independent of the phosphorylation at serine 15 in MCF-7 breast cancer cells,” Cancer Biology & Therapy, vol. 15, no. 8, pp. 1000–1012, 2014. View at Publisher · View at Google Scholar
  • Malgorzata K. Tuxen, and Dorte Lisbet Nielsen, “A systematic review of dual targeting in HER2-positive breast cancer,” Cancer Treatment Reviews, vol. 40, no. 2, pp. 259–270, 2014. View at Publisher · View at Google Scholar
  • Lijuan Yang, Yuexun Wang, Hua Guo, and Meiling Guo, “Synergistic Anti-Cancer Effects of Icariin and Temozolomide in Glioblastoma,” Cell Biochemistry and Biophysics, 2014. View at Publisher · View at Google Scholar
  • Dalila Naci, and Fawzi Aoudjit, “Alpha2beta1 integrin promotes T cell survival and migration through the concomitant activation of ERK/Mcl-1 and p38 MAPK pathways,” Cellular Signalling, 2014. View at Publisher · View at Google Scholar
  • Linlin Tang, Bin Yue, Yanna Cheng, Hong Yao, Xiaowen Ma, Qi Tian, Lianping Ge, Zhaopeng Liu, and Xiuzhen Han, “Inhibition of invasion and metastasis by DMBT, a novel trehalose derivative, through Akt/GSK-3 beta/beta-catenin pathway in B16BL6 cells,” Chemico-Biological Interactions, vol. 222, pp. 7–17, 2014. View at Publisher · View at Google Scholar
  • Hilde van Hattum, and Herbert Waldmann, “Chemical Biology Tools for Regulating RAS Signaling Complexity in Space and Time,” Chemistry & Biology, vol. 21, no. 9, pp. 1185–1195, 2014. View at Publisher · View at Google Scholar
  • Lidia Zueva, Yomarie Rivera, Lilia Kucheryavykh, Serguei N. Skatchkov, Misty J. Eaton, Priscila Sanabria, and Mikhail Inyushin, “Electron Microscopy in Rat Brain Slices Reveals Rapid Accumulation of Cisplatin on Ribosomes and Other Cellular Components Only in Glia,” Chemotherapy Research and Practice, vol. 2014, pp. 1–5, 2014. View at Publisher · View at Google Scholar
  • Ebenezer Tunde Olayinka, Ayokanmi Ore, Olaniyi Solomon Ola, and Oluwatobi Adewumi Adeyemo, “Protective Effect of Quercetin on Melphalan-Induced Oxidative Stress and Impaired Renal and Hepatic Functions in Rat,” Chemotherapy Research and Practice, vol. 2014, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  • Abhay Dhand, and George Sakoulas, “Daptomycin in Combination With Other Antibiotics for the Treatment of Complicated Methicillin-Resistant Staphylococcus aureus Bacteremia,” Clinical Therapeutics, vol. 36, no. 10, pp. 1303–1316, 2014. View at Publisher · View at Google Scholar
  • Giuseppe Bronte, Christian Rolfo, Elisa Giovannetti, Giuseppe Cicero, Patrick Pauwels, Francesco Passiglia, Marta Castiglia, Sergio Rizzo, Francesca Lo Vullo, Eugenio Fiorentino, Jan Van Meerbeeck, and Antonio Russo, “Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects,” Critical Reviews in Oncology Hematology, vol. 89, no. 2, pp. 300–313, 2014. View at Publisher · View at Google Scholar
  • Yuan Zhang, Yukun Liu, Yan Sun, Qingmei Liu, Xiaoyan Wang, Zhi Li, and Jie Hao, “In Vitro Synergistic Activities of Antimicrobial Peptide Brevinin-2CE with Five Kinds of Antibiotics Against Multidrug-Resistant Clinical Isolates,” Current Microbiology, vol. 68, no. 6, pp. 685–692, 2014. View at Publisher · View at Google Scholar
  • Megan Lyle, and Georgina V. Long, “The role of systemic therapies in the management of melanoma brain metastases,” Current Opinion in Oncology, vol. 26, no. 2, pp. 222–229, 2014. View at Publisher · View at Google Scholar
  • Deirdre R. Pachman, James C. Watson, and Charles L. Loprinzi, “Therapeutic Strategies for Cancer Treatment Related Peripheral Neuropathies,” Current Treatment Options in Oncology, vol. 15, no. 4, pp. 567–580, 2014. View at Publisher · View at Google Scholar
  • K. Chanprapaph, V. Vachiramon, and P. Rattanakaemakorn, “Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management,” Dermatology Research and Practice, vol. 2014, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  • Hale Colakoglu Er, Ayse Erden, N. Ozlem Kucuk, and Ethem Gecim, “Correlation of minimum apparent diffusion coefficient with maximum standardized uptake on fluorodeoxyglucose PET-CT in patients with rectal adenocarcinoma,” Diagnostic and Interventional Radiology, vol. 20, no. 2, pp. 105–109, 2014. View at Publisher · View at Google Scholar
  • Jorge Eduardo Toblli, and Margarita Angerosa, “Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose,” Drug Design Development And Therapy, vol. 8, pp. 2475–2491, 2014. View at Publisher · View at Google Scholar
  • Cheng-Cheung Chen, Dar-Shih Hsieh, Kao-Jean Huang, Yi-Lin Chan, Po-Da Hong, Ming-Kung Yeh-, and Chang-Jer Wu, “Improving anticancer efficacy of (-)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cells,” Drug Design Development and Therapy, vol. 8, pp. 459–473, 2014. View at Publisher · View at Google Scholar
  • Fatima el Bahhaj, Frank J. Dekker, Nadine Martinet, and Philippe Bertrand, “Delivery of epidrugs,” Drug Discovery Today, 2014. View at Publisher · View at Google Scholar